F
ahr's disease (FD) refers to a sporadic or familial idiopathic calcification of the basal ganglia that may lead to neurological, psychiatric, and cognitive abnormalities. Patients with FD mostly present with movement disorders such as parkinsonism, chorea, tremor, dystonia, dysarthria, paresis, or speech impairment. Other common neurological features are seizures, syncope, or stroke-like events, often combined with a frontal subcortical pattern of behavioural dysfunction and psychiatric symptoms such as psychosis, mood disorders, and dementia. 1 2 The origin and pathomechanism of this disorder are unknown, as is the reason why other cases with basal ganglia calicification remain asymptomatic. 3 Fluoro-L-dopa uptake was found normal in a study of FD patients, suggesting an intact nigrostriatal dopaminergic pathway. 4 However, two single case studies have found reduced focal cerebral blood flow and glucose metabolism 5 6 , thus the observed symptoms may be manifestations of a cortico-subcortical disconnection. It is therefore of special interest to determine which parts of the brain show reduced metabolism in FD, and whether areas of hypometabolism correspond with the clinical picture. The present report documents neurobehavioural and imaging data in parallel in order to further analyse the relationship between behavioural, structural, and metabolic findings in FD.
CASE REPORT
A 50 year old, previously healthy man presented with a 6 month history of personality change and an impairment of planning and memory functions. He had led an active and successful life as a general practitioner until he rapidly became unable to continue his work because of cognitive deficits, attention problems, irritability, mood changes (dysphoria alternating with episodes of constricted affect and anxiety), and ritualised behaviours. The patient had no history of alcohol or drug abuse. The family history was unremarkable regarding dementia or FD. His neurological examination was normal, as was his orientation and language. A neuropsychological investigation showed a severe impairment of memory functions, verbal more than figural, and reduced psychomotor speed and verbal associative skills (table 1), but no ideomotor apraxia, dysarthria, or visuoconstructive impairment. On a computerised test battery measuring alertness, divided attention, and the suppression of irrelevant stimuli, 7 the patient's reaction times were drastically slowed and he committed many errors. CT and MRI showed bilateral calcifications in the basal ganglia, mostly in the pallidum, but there was no frontal or temporal atrophy. Brain 18-fluorodeoxyglucose positron emission tomography (FDG-PET) was performed with an Advance PET scanner (General Electric Medical Systems, Milwaukee, USA), and showed a massive reduction of glucose metabolism in the basal ganglia and both frontal lobes (fig 1) . Laboratory and endocrinological investigations were all normal. In particular, screening for hypoparathyroidism, iron or copper deficiencies, mitochondrial encephalopathies, encephalitis, and Creutzfeld-Jakob disease were all negative, and serum and urine calcium metabolism was normal. No thyroid disease or vitamin deficiency could be found. The EEG was normal.
Twelve months after disease onset, the patient's cognitive and behavioural functions had further deteriorated. Learning and spontaneous recall of a 16 item word list had further declined, and he made many errors of committment and perseverations during memory tests. The most striking deficits were found on tasks measuring executive functions. Owing to continuous perseverations and rule breaking behaviour, he was unable to perform the Action Program Test, a task requiring simple, practical, problem solving abilities. 8 On the ''odd man out'' choice discrimination task, in which subjects have to alternate between two different rules, his set shifting abilities appeared completely eradicated. 9 Similarly, suppression of irrelevant stimuli, as demanded in a simple interference naming task, was impossible. Verbal fluency was grossly impaired. Timed tests of attention including alertness, and divided and selective attention showed markedly slowed reaction times or could not be performed (go/no go task; table 1). His behaviour was now characterised by apathy, intermittent disinhibition, distractability, poor impulse control, increasing antisocial behaviour and physical aggression, compulsions and anxiety. He also lost all insight into his condition. External rating by his wife on the Neuropsychiatric Inventory 10 showed particular elevation of the subscales agitation/aggression, Abbreviations: FD, Fahr's disease; FDG-PET, fluorodeoxyglucose positron emission tomography irritability/lability, disinhibition, and dysphoria. The Frontal Systems Behavior Scale, 11 a validated scale designed to measure behaviours associated with frontal lobe damage based on family ratings, revealed markedly increased apathy, disinhibition, and reduction of executive abilities. At month 14 he became increasingly psychotic and was observed to hallucinate visually. He was now unable to imitate alternating hand movements or perform anti-saccades, whereas his other motor, oculomotor, and speech functions were still unremarkable.
DISCUSSION
The predominant deficit in this case of FD was a severe impairment of executive functions, mainly including planning, problem solving, and set shifting capacities, but also flexibility and divergent thinking. Furthermore, episodic memory and attentional functions were also grossly compromised. In contrast, basic and higher motor functions, language and basic perceptual abilities remained unimpaired. In addition, the patient experienced a marked personality change with apathy, intermittent disinhibition, irritability, aggression, compulsive features, and anxiety. The functional imaging correlate of the basal ganglia calcification was a regional hypometabolism of the basal ganglia and frontal brain as shown by FDG-PET, whereas brain regions located more posteriorly appeared to have normal metabolism. Hypometabolism in both frontal lobes was extensive and included dorsolateral, ventromedial, and orbitofrontal areas.
The origin of this patient's disorder is not clear. Combinations of FD with other neurological conditions have been reported, among them corticobasal degeneration, 12 mitochondrial encephalopathy, central nervous system lupus, motor neurone disease, Alzheimer's disease, or frontal lobe dementia. 2 Although none of these disorders can be ruled out completely without histopathology, the basal ganglia lesions remain a crucial finding. The concept of frontal-subcortical circuits, 13 a system of loops linking the basal ganglia and frontal brain regions provides a useful, but still hypothetical framework for the interpretation of cognitive and psychiatric disorders in patients with basal ganglia disorders. According to this hypothesis, impairment of executive functions in basal ganglia disorders results from a disruption of the dorsolateral fronto-striatal circuit.
14 Loss of executive control is also known to produce memory deficits due to loss of organisational, strategic, and monitoring skills necessary for such tasks as list learning, and may follow disruption of the dorsolateral-striatal circuit both at the cortical 15 and the basal ganglial level. 16 Attentional dysfunction, including impairment of alertness and of sustained, directed, and divided attention is a frequent finding following dorsolateral and ventromedial prefrontal lesions. [17] [18] [19] [20] Further regions of hypometabolism in our patient were found in orbitofrontal and anterior cingulate areas, which are important parts of the limbic system. Lesions in these areas or the connecting lateral orbitofrontal circuit produce socially inappropriate behaviour, impulsivity, obsessive2compulsive and mood disorders, and personality change 14 21-23 , all of which were part of the behavioural disorder of the present case. These impairments stand in contrast to well preserved cognitive functions such as language or praxis, which are functionally linked with temporal and parietal brain areas showing normal metabolism. Similarly, the patient did not show any of the frequently encountered motor deficits of FD, such as parkinsonism, paresis, spasticity, or gait disorder, 2 suggesting that his ''motor loops'' were intact. Only oculomotor impairment was observed during advanced disease stages.
The present case illustrates that FD may present neurologically ''asymptomatic''-that is, lacking movement disorders, seizures, or stroke-like events, 2 but with pronounced, rapidly progressive cognitive and behavioural abnormalities. A clear cut correslation was found between neuropsychiatric features and areas of focal hypometabolism as mapped by FDG-PET. As in other basal ganglia disorders, functional imaging and the concept of cortico-subcortical loops provide a promising account of the underlying mechanism. Although slightly different patterns of hypometabolism have also been found, 5 6 FD appears to be a basal ganglia disorder associated with dysfunction in predominantly frontal cortical areas.
